BMINCT07906626
Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Interventions: Snakehead Fish Extract and Curcumin (Drug) to Placebo (Drug), Snakehead Fish Extract and Curcumin (Drug)
- Study arms: 1 to 2
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Change from baseline in body weight at 9 weeks
Timeframe: Baseline and After 9 weeks
Secondary (8)
Change from baseline in serum C-reactive protein (CRP) levels at 9 weeks
Change from baseline in serum tumor necrosis factor-alpha (TNF-alpha) levels at 9 weeks
Change from baseline in serum interleukin-6 (IL-6) levels at 9 weeks
Change from baseline in mid-upper arm circumference (MUAC) at 9 weeks
Change from baseline in Body Mass Index (BMI) at 9 weeks
Show 3 moreShow less
Change from baseline in EORTC QLQ-C30 functional scale scores at 9 weeks
Change from baseline in EORTC QLQ-C30 symptom scale scores at 9 weeks
Change from baseline in EORTC QLQ-C30 global health status score at 9 weeks
Arms and interventions
INTERVENTIONExperimental
PLACEBOExperimental
Participants receive matching placebo capsules containing inert substances (e.g., starch/fillers) administered at the same frequency and duration (2 capsules 3 times daily for 3 months) to match the intervention regimen.
Drugs: Snakehead Fish Extract and Curcumin, Placebo
Sites
1 site in 1 country
- Universitas Sumatera UtaraMedan, North Sumatra, Indonesia